使用跨学科远程高血压程序改善高风险慢性病患者的血压
Molly C Fisher1, Sharon Rikin2, Sonali Gupta1
1Division of Nephrology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, New York, USA.
Kidney international reports
|April 30, 2025
概括
这项研究表明,远程患者监测 (RPM) 在患有慢性病 (CKD) 的黑人和西班牙裔患者中有效改善血压 (BP) 控制. 该计划展示了高可行性和显著的BP降低,提供了一个有希望的方法来减少健康差异.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 健康 公平 卫生 公平
背景情况:
- 在慢性病 (CKD) 患者中,在实现血压 (BP) 控制方面仍然存在种族和民族差异.
- 需要采取干预措施来解决这些差异,并改善脆弱人群的高血压管理.
- 远程患者监测 (RPM) 提供了一个潜在的解决方案,用于加强慢性病患者的高血压管理.
研究的目的:
- 确定跨学科RPM高血压计划的可行性和有效性.
- 评估该计划对主要是黑人和西班牙裔患有慢性病患者的血压控制的影响.
- 评估RPM在降低高血压管理中的种族和民族差异方面的潜力.
主要方法:
- 一个RPM高血压计划在纽约市卫生系统中进行了评估 (2021年7月至2022年10月).
- 患者使用蜂支持的BP设备进行实时数据传输,接受生活方式教育和基于远程医疗的药物调整.
- 通过招生,参与和保留率来评估可行性;血压控制通过3个月后的平均血压变化和6个月后达到血压<130/80 mmHg的比例来衡量血压控制.
主要成果:
- 该计划表现出高可行性,在受邀患者中,招募率为91.9%,在3个月内保留率为78.4%.
- 3个月后观察到静脉血压 (-15.0 mmHg) 和静脉血压 (-6.7 mmHg) 的显著平均降低 (分别P < 0.0001和P = 0.0007).
- 在6个月后,49.4%的参与者达到130/80mmHg以下的目标血压.
结论:
- 跨学科的RPM高血压计划在改善慢性病患者的血压控制方面是可行的和有效的.
- 这种方法有望提高高血压管理的公平性,特别是在种族和少数民族群体中.
- 需要进一步的研究来评估与常规护理相比,使用RPM维持血压控制的长期维持.
相关概念视频
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Antihypertensive Drugs: Direct Renin Inhibitors
439
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
439
Antihypertensive Drugs: Potassium-Sparing Diuretics
398
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
398
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Heart Failure Drugs: Diuretics
277
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
277


